Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Science (New York, N.Y.)|May 23, 2009
MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in miceAngelika Bonauer, Guillaume Carmona, Masayoshi Iwasaki, et al.
The Oncologist|June 1, 2023
A Phase I Trial of the Dual MET Kinase/OCT-2 Inhibitor OMO-1 in Metastatic Solid Malignancies Including MET Exon 14 Mutated Lung CancerMelinda A Pruis, Matthew G Krebs, Ruth Plummer, et al.
Nature Medicine|June 8, 2002
Loss of HIF-2alpha and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fatal respiratory distress in premature miceVeerle Compernolle, Koen Brusselmans, Till Acker, et al.
European Heart Journal|January 4, 2011
Hepatocyte growth factor mobilizes non-bone marrow-derived circulating mesoangioblastsMasayoshi Iwasaki, Masamichi Koyanagi, Hans Kossmann, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 29, 2014
Supporting roles of platelet thrombospondin-1 and CD36 in thrombus formation on collagenMarijke J E Kuijpers, Susanne de Witt, Reyhan Nergiz-Unal, et al.
The Journal of Cell Biology|September 6, 2007
uPA deficiency exacerbates muscular dystrophy in MDX miceMònica Suelves, Berta Vidal, Antonio L Serrano, et al.
The EMBO Journal|December 17, 2009
Increased skeletal VEGF enhances beta-catenin activity and results in excessively ossified bonesChrista Maes, Steven Goossens, Sonia Bartunkova, et al.
The American Journal of Pathology|August 25, 2007
Tumoral and choroidal vascularization: differential cellular mechanisms involving plasminogen activator inhibitor type IMaud Jost, Catherine Maillard, Julie Lecomte, et al.
Genes & Development|July 3, 2008
Fibrinogen drives dystrophic muscle fibrosis via a TGFbeta/alternative macrophage activation pathwayBerta Vidal, Antonio L Serrano, Marc Tjwa, et al.
Cancer Cell|August 16, 2005
Genetic evidence for a tumor suppressor role of HIF-2alphaTill Acker, Antonio Diez-Juan, Julian Aragones, et al.
Pageof 6